EN IT

Evommune: 11 Weeks Into the Decline, Distribution Still Dominant

Evommune is at week 11 of a sell signal, with a 10.6% gain from inception. The week was nearly flat, but distribution remains dominant and sellers control the flow. No reversal signal in sight.

Evommune: 11 Weeks Into the Decline, Distribution Still Dominant
US Stocks · Ongoing Decline · Week 11
Evommune: 11 Weeks Into the Decline, Distribution Still Dominant
June 12, 2026
US Stocks · Ongoing Decline · Week 11
In Summary
Evommune is at week 11 of a sell signal, with a 10.6% gain from trade inception. The week closed nearly flat (-0.5%), yet the technical picture underneath is more bearish than the price move suggests: CMF at -0.286 and SellVol at 76% confirm distribution remains dominant. No reversal signal is visible in the current setup.
Ongoing decline ·11th week from start ·US stocks ·T2
IQS Phase
66
in tension
Signal Strength
8
indecisive week
Sizing
MINIMUM
Ranking
#47 / 114
US stocks
Trade P&L %
+10.60%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn